PageIndex, a new open-source framework, achieves 98.7% accuracy on complex document retrieval by using tree search instead of ...
After a series of deaths in patients taking Sarepta Therapeutics’ gene therapies, doubt has crept into investor sentiments ...
U.S agencies and Indian authorities are working together to stop fentanyl before it enters the American market.
Direct aviation is empowered by Electra’s core technology—ultra-short-takeoff-and-landing using blown lift enabled by ...
A hushed quiet and a palpable chill in both temperature and atmosphere falls over the cellar of Vaughan, Ont.’s Magnotta Winery as Rosanna Magnotta takes a moment to reflect in the presence of the ...
A central nervous system (CNS) tumor has prompted the FDA to place clinical holds on two Regenxbio gene therapies, including ...
The Virtual Boy emulation on Switch captures one of Nintendo's most notorious missteps, but it feels made for serious history ...
This absence of interiority can be described as a deficit, as if something essential were missing. But another way to see it ...
Ralliant Corporation ( RAL) Q4 2025 Earnings Call February 5, 2026 8:30 AM EST ...
Clever research reveals that therapy-oriented AI chats can cause AI to act delusionally. The root is AI personas. I explain ...
Neurophos is taking a crack at solving the AI industry's power efficiency problem with an optical chip that uses a composite material to do the math required in AI inferencing tasks.
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results